|
Treatment Comparisons of the Retention Rate at 1 Year (ITT Population) |
|||||
| Treatment group |
N |
Retention rate, n (%) |
Contrasts |
Estimated difference (97.5% CI) |
Outcome |
|
|
|||||
| Lumiracoxib 100 mg |
755 |
354 (46.9) |
Lumiracoxib 100 mg o.d. |
0.02 (-0.04, 0.07) |
Non-inferior |
| o.d. |
- celecoxib 200 mg o.d. |
||||
| Lumiracoxib 100 mg |
1519 |
722 (47.5) |
Lumiracoxib 100 mg b.i.d. |
0.02 (-0.03, 0.07) |
Non-inferior |
| b.i.d. |
- celecoxib 200 mg o.d. |
||||
| Celecoxib 200 mg |
758 |
343 (45.3) |
|||
| o.d. |
|||||
|
CI = confidence interval; o.d. = once daily; b.i.d. = twice daily; ITT = intention-to-treat. | |||||
Fleischmann et al. BMC Musculoskeletal Disorders 2008 9:32 doi:10.1186/1471-2474-9-32 |
|||||